These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 7995942)

  • 1. A simple mathematical model for the functional peptide/MHC/TCR interactions.
    Eberl G; Roggero MA; Corradin G
    J Immunol; 1995 Jan; 154(1):219-25. PubMed ID: 7995942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A molecular basis for how a single TCR interfaces multiple ligands.
    Boesteanu A; Brehm M; Mylin LM; Christianson GJ; Tevethia SS; Roopenian DC; Joyce S
    J Immunol; 1998 Nov; 161(9):4719-27. PubMed ID: 9794402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of strict correlation of functional sensitization with the apparent affinity of MHC/peptide complexes for the TCR.
    al-Ramadi BK; Jelonek MT; Boyd LF; Margulies DH; Bothwell AL
    J Immunol; 1995 Jul; 155(2):662-73. PubMed ID: 7541822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alloreactive and syngeneic CTL are comparably dependent on interaction with MHC class I alpha-helical residues.
    Hornell TM; Solheim JC; Myers NB; Gillanders WE; Balendiran GK; Hansen TH; Connolly JM
    J Immunol; 1999 Sep; 163(6):3217-25. PubMed ID: 10477590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a murine mutant Ras CD8+ CTL peptide epitope variant that possesses enhanced MHC class I binding and immunogenic properties.
    Bristol JA; Schlom J; Abrams SI
    J Immunol; 1998 Mar; 160(5):2433-41. PubMed ID: 9498787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. V beta 5+ T cell receptors skew toward OVA+H-2Kb recognition.
    Dillon SR; Jameson SC; Fink PJ
    J Immunol; 1994 Feb; 152(4):1790-801. PubMed ID: 8120388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fab antibodies capable of blocking T cells by competitive binding have the identical specificity but a higher affinity to the MHC-peptide-complex than the T cell receptor.
    Neumann F; Sturm C; Hülsmeyer M; Dauth N; Guillaume P; Luescher IF; Pfreundschuh M; Held G
    Immunol Lett; 2009 Aug; 125(2):86-92. PubMed ID: 19524620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The orientation and nature of the interaction between beef insulin-specific TCRs and the insulin/class II MHC complex.
    Wither JE; Vukusic B
    J Immunol; 1999 Feb; 162(4):2113-22. PubMed ID: 9973485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenous generation and presentation of the ovalbumin peptide/Kb complex to T cells.
    Shastri N; Gonzalez F
    J Immunol; 1993 Apr; 150(7):2724-36. PubMed ID: 8454852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in TCR-MHC contacts subsequent to cross-recognition of class I MHC and singly substituted peptide variants.
    Ono T; DiLorenzo TP; Wang F; Kalergis AM; Nathenson SG
    J Immunol; 1998 Nov; 161(10):5454-63. PubMed ID: 9820521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Class II MHC/peptide complexes are released from APC and are acquired by T cell responders during specific antigen recognition.
    Patel DM; Arnold PY; White GA; Nardella JP; Mannie MD
    J Immunol; 1999 Nov; 163(10):5201-10. PubMed ID: 10553040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The duration of TCR/pMHC interactions regulates CTL effector function and tumor-killing capacity.
    Riquelme E; Carreño LJ; González PA; Kalergis AM
    Eur J Immunol; 2009 Aug; 39(8):2259-69. PubMed ID: 19637198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unique T cell antagonist properties of the exact self-correlate of a peptide antigen revealed by self-substitution of non-self-positions in the peptide sequence.
    Schountz T; Kasselman JP; Ford SR; Murray JS
    Cell Immunol; 1996 Mar; 168(2):193-200. PubMed ID: 8640865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T cells down-modulate peptide-MHC complexes on APCs in vivo.
    Kedl RM; Schaefer BC; Kappler JW; Marrack P
    Nat Immunol; 2002 Jan; 3(1):27-32. PubMed ID: 11731800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Manifestation of the MHC-unrestricted killing potential of a cytotoxic T cell clone requires activation in response to MHC-restricted self-presentation of antigen.
    Dick T; Staege MS; Reichmann G; Reske-Kunz AB
    J Immunol; 1993 Apr; 150(7):2575-83. PubMed ID: 8454844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Competition of peptide-MHC class I tetrameric complexes with anti-CD3 provides evidence for specificity of peptide binding to the TCR complex.
    Hoffmann TK; Donnenberg VS; Friebe-Hoffmann U; Meyer EM; Rinaldo CR; DeLeo AB; Whiteside TL; Donnenberg AD
    Cytometry; 2000 Dec; 41(4):321-8. PubMed ID: 11084618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural basis of specificity and degeneracy of T cell recognition: pluriallelic restriction of T cell responses to a peptide antigen involves both specific and promiscuous interactions between the T cell receptor, peptide, and HLA-DR.
    Doherty DG; Penzotti JE; Koelle DM; Kwok WW; Lybrand TP; Masewicz S; Nepom GT
    J Immunol; 1998 Oct; 161(7):3527-35. PubMed ID: 9759873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-12 is both required and sufficient for initiating T cell reactivity to a class I-restricted tumor peptide (P815AB) following transfer of P815AB-pulsed dendritic cells.
    Bianchi R; Grohmann U; Belladonna ML; Silla S; Fallarino F; Ayroldi E; Fioretti MC; Puccetti P
    J Immunol; 1996 Aug; 157(4):1589-97. PubMed ID: 8759743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virus infection expands a biased subset of T cells that bind tetrameric class I peptide complexes.
    Coles RM; Jones CM; Brooks AG; Cameron PU; Heath WR; Carbone FR
    Eur J Immunol; 2003 Jun; 33(6):1557-67. PubMed ID: 12778473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defective CD8+ T cell activation and cytolytic function in the absence of LFA-1 cannot be restored by increased TCR signaling.
    Shier P; Ngo K; Fung-Leung WP
    J Immunol; 1999 Nov; 163(9):4826-32. PubMed ID: 10528183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.